Physician profile
John Michael Evans
NPI 1851681217
$4,328.75
in general payments reported to CMS, 2019-2025
12 companies · $623 in 2025
The $623 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $1,796 · 2021: $928 · 2022: $100 · 2023: $438 · 2024: $322 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,914.22 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $636.60 | 2019-2024 | Inspiris Resilia Aortic Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Konect Resilia |
| Ethicon US, LLC | $445.72 | 2020-2025 | Evarrest, Ethicon |
| Silk Road Medical, INC. | $271.51 | 2020-2021 | |
| Baxter Healthcare | $201.47 | 2020-2023 | Floseal |
| Kls-Martin L.P. | $199.61 | 2020-2024 | |
| Abbott Laboratories | $170.93 | 2021 | |
| Abiomed | $135.63 | 2023-2025 | Impella |
| Elutia, INC. | $131.65 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.50 | 2020-2024 | Lifevest |
| Medtronic, INC. | $76.51 | 2022-2023 | Endurant Iis, Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $18.40 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.